Benzinga··Vandana SinghEsperion Therapeutics Surges on $1.1B Archimed Acquisition Deal
Esperion Therapeutics shares surge following $1.1B Archimed acquisition announcement at $3.16 per share plus contingent value rights.
ESPRacquisitioncontingent value rights